Aflibercept Rescue of Bevacizumab- or Ranibizumab-Resistant Choroidal Neovascularization in Age-Related Macular Degeneration

被引：0
|
作者：
Arcinue, Cheryl [1 ]
Ma, Feiyan [1 ]
Barteselli, Giulio [1 ]
Lee, Su-Na [1 ]
El-Emam, Sharif [1 ]
Doede, Aubrey [1 ]
Gomez, Maria Laura [1 ]
Freeman, William [1 ]
机构：
[1] UCSD Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
453 choroid: neovascularization; 412 age-related macular degeneration; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4176
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Effect of Aflibercept and Bevacizumab for Ranibizumab-Refractory Exudative Age-Related Macular Degeneration
    Kim, Bo Hee
    Seo, Young Seung
    Chung, Hum
    Heo, Jang Won
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [22] Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
    Spaide, Richard F.
    Laud, Ketan
    Fine, Howard F.
    Klancnik, James M., Jr.
    Meyerle, Catherine B.
    Yannuzzi, Lawrence A.
    Sorenson, John
    Slakter, Jason
    Fisher, Yale L.
    Cooney, Michael J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (04): : 383 - 390
  • [23] Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
    Aisenbrey, S.
    Ziemssen, F.
    Voelker, M.
    Gelisken, F.
    Szurman, P.
    Jaissle, G.
    Grisanti, S.
    Bartz-Schmidt, K. U.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (07) : 941 - 948
  • [24] Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia
    Hashemi, Saba
    Faramarzi, Mohammad Ali
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (12) : 1837 - 1848
  • [25] Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
    S. Aisenbrey
    F. Ziemssen
    M. Völker
    F. Gelisken
    P. Szurman
    G. Jaissle
    S. Grisanti
    K. U. Bartz-Schmidt
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 245 : 941 - 948
  • [26] Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
    Rothenbuehler, Simon P.
    Waeber, David
    Brinkmann, Christian K.
    Wolf, Sebastian
    Wolf-Schnurrbusch, Ute E. K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (05) : 831 - 837
  • [27] INTRAVITREAL RANIBIZUMAB FOR NAIVE EXTRAFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
    Parodi, Maurizio B.
    Iacono, Pierluigi
    La Spina, Carlo
    Iuliano, Lorenzo
    Lo Giudice, Giuseppe
    Introini, Ugo
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (11): : 2167 - 2170
  • [28] INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION WITH LARGE SUBMACULAR HEMORRHAGE IN AGE-RELATED MACULAR DEGENERATION
    Iacono, Pierluigi
    Parodi, Maurizio B.
    Introini, Ugo
    La Spina, Carlo
    Varano, Monica
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (02): : 281 - 287
  • [29] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [30] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    International Ophthalmology, 2017, 37 : 1205 - 1214
12345